Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients

Luit Penninga; Ida Elisabeth Irene Penninga; Christian H Møller; Martin Iversen; Daniel A Steinbrüchel; Christian Gluud

doi:10.1002/14651858.CD008817.pub2

Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients

Luit Penninga, Ida Elisabeth Irene Penninga, Christian H Møller, Martin Iversen, Daniel A Steinbrüchel, Christian Gluud

105 Citations (Scopus)

Abstract

Lung transplantation is a well-accepted treatment for people with most end-stage lung diseases. Although both tacrolimus and cyclosporin are used as primary immunosuppressive agents in lung transplant recipients, it is unclear which of these drugs is better in reducing rejection and death without causing adverse effects.

Original language	English
Journal	Cochrane Database of Systematic Reviews
Volume	5
Pages (from-to)	CD008817
ISSN	1469-493X
DOIs	https://doi.org/10.1002/14651858.CD008817.pub2
Publication status	Published - 2013

Access to Document

10.1002/14651858.CD008817.pub2

Cite this

@article{d605630d76c846b9a0ee65de04db6a3e,

title = "Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients",

abstract = "Lung transplantation is a well-accepted treatment for people with most end-stage lung diseases. Although both tacrolimus and cyclosporin are used as primary immunosuppressive agents in lung transplant recipients, it is unclear which of these drugs is better in reducing rejection and death without causing adverse effects.",

author = "Luit Penninga and Penninga, \{Ida Elisabeth Irene\} and M{\o}ller, \{Christian H\} and Martin Iversen and Steinbr{\"u}chel, \{Daniel A\} and Christian Gluud",

year = "2013",

doi = "10.1002/14651858.CD008817.pub2",

language = "English",

volume = "5",

pages = "CD008817",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "John Wiley and Sons Ltd",

}

TY - JOUR

T1 - Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients

AU - Penninga, Luit

AU - Penninga, Ida Elisabeth Irene

AU - Møller, Christian H

AU - Iversen, Martin

AU - Steinbrüchel, Daniel A

AU - Gluud, Christian

PY - 2013

Y1 - 2013

N2 - Lung transplantation is a well-accepted treatment for people with most end-stage lung diseases. Although both tacrolimus and cyclosporin are used as primary immunosuppressive agents in lung transplant recipients, it is unclear which of these drugs is better in reducing rejection and death without causing adverse effects.

AB - Lung transplantation is a well-accepted treatment for people with most end-stage lung diseases. Although both tacrolimus and cyclosporin are used as primary immunosuppressive agents in lung transplant recipients, it is unclear which of these drugs is better in reducing rejection and death without causing adverse effects.

UR - https://www.scopus.com/pages/publications/84891681620

U2 - 10.1002/14651858.CD008817.pub2

DO - 10.1002/14651858.CD008817.pub2

M3 - Journal article

C2 - 23728681

SN - 1469-493X

VL - 5

SP - CD008817

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

ER -

Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients

Abstract

Access to Document

Other files and links

Fingerprint

Cite this